|1.||Atopic Dermatitis (Atopic Eczema)
|4.||Rosacea (Acne Rosacea)
|5.||Graft vs Host Disease (Graft-Versus-Host Disease)
|1.||Dogru, Murat: 8 articles (11/2014 - 01/2007)|
|2.||Fujishima, Hiroshi: 8 articles (11/2014 - 01/2007)|
|3.||Tsubota, Kazuo: 7 articles (11/2014 - 08/2002)|
|4.||Uchio, Eiichi: 7 articles (01/2014 - 11/2002)|
|5.||Angelos, John A: 7 articles (10/2012 - 09/2004)|
|6.||Shoji, Jun: 6 articles (01/2015 - 10/2003)|
|7.||Fukagawa, Kazumi: 6 articles (08/2013 - 01/2007)|
|8.||Kadonosono, Kazuaki: 5 articles (01/2014 - 11/2002)|
|9.||Ebihara, Nobuyuki: 5 articles (09/2012 - 01/2005)|
|10.||Matsumoto, Yukihiro: 5 articles (08/2010 - 01/2007)|
|1.||Cyclosporine (Ciclosporin)FDA LinkGeneric
02/01/2008 - "To report the efficacy of topical cyclosporine A (CsA) 0.05% drops (Restasis; Allergan, Irvine, CA) in the treatment of superior limbic keratoconjunctivitis (SLK). "
08/01/2003 - "Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis."
03/01/2004 - "A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis."
09/01/1998 - "A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis."
10/01/2013 - "Successful treatment of phlyctenular keratoconjunctivitis with topical cyclosporin A."
|2.||Ophthalmic Solutions (Eye Drops)IBA
01/01/2011 - "Report a case of limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis. "
01/01/2011 - "Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis."
06/02/2007 - "Regarding both topics it was decided not to change the recommendations of the former version of the guideline: the use of slit lamp biomicroscopy remains optional for general practitioners and it remains permitted to give the remainder of a 'minim' with anaesthetic eye drops to a patient with keratoconjunctivitis photoelectrica."
06/02/2007 - "During revision of the guideline discussions concentrated on 2 aspects: the position of slit lamp biomicroscopy in general practice and giving a patient with keratoconjunctivitis photoelectrica the remainder of a 'minim' with anaesthetic eye drops. "
02/01/1966 - "[Effect of ABOB [N'-N'-anhydro-bis (beta-hydroethyl) biguanide hydrochloride] eye drops on epidemic keratoconjunctivitis]."
|3.||Tacrolimus (Prograf)FDA LinkGeneric
05/01/2014 - "Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis."
02/01/2014 - "To evaluate the long-term clinical outcomes of 0.1% tacrolimus dermatologic ointment (Protopic) in cases of refractory atopic keratoconjunctivitis (AKC). "
02/01/2014 - "Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis."
11/01/2013 - "To report 2 cases of superior limbic keratoconjunctivitis (SLK) treated with topical tacrolimus 0.03% ointment (Protopic; Fujisawa Healthcare). "
11/01/2013 - "Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment."
08/01/2001 - "Identification of this gene and expression of recombinant cytotoxin could facilitate the development of improved vaccines against infectious bovine keratoconjunctivitis."
07/01/1995 - "Nevertheless, the levels of protection against infectious bovine keratoconjunctivitis (IBK) achieved with multivalent vaccines were 72% and 83% for the groups challenged with M. "
08/01/2005 - "Current work targeting conserved immunogens provides hope for efficacious vaccines that when used in tandem with proper management may control, if not prevent, infectious bovine keratoconjunctivitis."
08/20/1999 - "Type 4 fimbriae form the basis of vaccines against ovine footrot and bovine keratoconjunctivitis. "
07/01/1990 - "Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines."
|5.||Tetracycline (Achromycin)FDA LinkGeneric
09/01/1993 - "Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline."
10/01/1991 - "Tetracycline administered in low doses can be effective in the long-term management of patients with meibomian keratoconjunctivitis (MKC). "
08/01/1981 - "We believe oral tetracycline is a safe and effective treatment for resistant and recurrent nontuberculous phlyctenular keratoconjunctivitis and an alternative to topical corticosteroid treatment in those patients suffering from corticosteroid-induced complications."
08/01/1981 - "Orally administered tetracycline for phlyctenular keratoconjunctivitis."
08/01/1981 - "We treated six patients who had recurrent episodes of nontuberculous phlyctenular keratoconjunctivitis and progressive corneal vascularization and scarring with oral tetracycline. "
|6.||Povidone-Iodine (Betadine)FDA LinkGeneric
02/01/2012 - "The purpose of this study was to analyze the outcome of treating epidemic keratoconjunctivitis (EKC) with 2% povidone-iodine (PVP-I) solution. "
02/01/2012 - "Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study."
11/01/1985 - "The good results obtained in the treatment of bacterial and viral keratoconjunctivitis with PVP iodine led to this study of the preoperative preparation of 41 eyes prior to cataract extraction."
01/01/2011 - "To determine the efficacy of a new formulation of topical dexamethasone 0.1%/povidone-iodine 0.4% (FST-100) in reducing clinical symptoms and infectious viral titers in a rabbit model of adenoviral keratoconjunctivitis. "
01/01/2011 - "Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis."
|7.||Oxytetracycline (Terramycin)FDA Link
01/01/1995 - "Role of oxytetracycline dihydrate in the treatment of mycoplasma-associated ovine keratoconjunctivitis in lambs."
02/15/1998 - "Combined parenteral and oral administration of oxytetracycline for control of infectious bovine keratoconjunctivitis."
05/15/1988 - "The effectiveness of topically applied furazolidone (FZ) or parenterally administered oxytetracycline (OTC) for treatment of infectious bovine keratoconjunctivitis was determined in a field study. "
05/15/1988 - "Topically applied furazolidone or parenterally administered oxytetracycline for the treatment of infectious bovine keratoconjunctivitis."
02/15/1998 - "To determine whether combined parenteral and oral administration of oxytetracycline would ameliorate a herd outbreak of infectious bovine keratoconjunctivitis (IBK) and to compare efficacy of this regimen with that of subconjunctival administration of procaine penicillin G. "
08/15/2006 - "A single dose of tulathromycin (SC) was an effective treatment of calves with experimentally induced infectious bovine keratoconjunctivitis. "
08/15/2006 - "To evaluate the clinical efficacy of a single injection of tulathromycin, compared with saline (0.9% NaCl) solution-treated control calves, for treatment of induced infectious bovine keratoconjunctivitis in calves. "
08/15/2006 - "The long serum half-life of tulathromycin, along with the results of this trial, suggests that tulathromycin may be a rational choice as a single-injection treatment for infectious bovine keratoconjunctivitis."
06/01/2014 - "Tulathromycin is approved in the United States for the treatment of respiratory disease in bovine and swine, infectious bovine keratoconjunctivitis associated with Moraxella bovis, and interdigital necrobacillosis in bovine. "
11/01/2013 - "The discovery of tulathromycin and its registration in multiple countries has been important for the food animal industry as it has been used successfully to treat economically important conditions such as bovine and porcine respiratory disease, infectious bovine keratoconjunctivitis and interdigital necrobacillosis. "
|9.||lodoxamide tromethamine (Alomide)FDA Link
09/01/1995 - "Topically applied lodoxamide tromethamine 0.1% is useful in the treatment of superior limbic keratoconjunctivitis. "
09/01/1995 - "We studied the efficacy of topically applied lodoxamide tromethamine 0.1% in the treatment of superior limbic keratoconjunctivitis. "
09/01/1995 - "Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis."
07/01/1998 - "Clinical studies carried out in 170 patients demonstrated a high efficacy of alomide in the treatment of subacute and chronic pollenosis conjunctivitis, spring keratoconjunctivitis, multiple and toxic allergic keratitis, and other allergic conjunctivities. "
07/01/1998 - "[Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis]."
05/01/1993 - "hellem keratoconjunctivitis confirmed with light, electron, and immunofluorescence microscopy that resolved promptly with topical fumagillin, a crystalline antibiotic with proven efficacy against Encephalitozoon species. "
01/01/1994 - "Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin."
06/01/1996 - "The keratoconjunctivitis resolved after three weeks of therapy with topical fumagillin. "
09/01/1995 - "Although a curative agent has yet to be discovered, fumagillin represents a safe, effective, low-cost, topical agent for the treatment of microsporidial keratoconjunctivitis."
09/01/1995 - "The patient was diagnosed with bilateral microsporidial keratoconjunctivitis and fumagillin therapy was initiated. "
09/01/2010 - "To compare the efficacy of conjunctival resection versus conjunctival resection with amniotic membrane graft (AMG) in patients with superior limbic keratoconjunctivitis not responsive to medical therapies. "
11/01/2013 - "Patients suffering from severe chronic atopic keratoconjunctivitis and its complications can benefit from suitable surgical treatments: transplants, covers, fillings, or corneal graft surgeries supplemented with AMFs."
09/01/2010 - "Conjunctival resection with and without amniotic membrane graft for the treatment of superior limbic keratoconjunctivitis."
11/01/2006 - "Microsporidia keratoconjunctivitis in a corneal graft."
01/01/1991 - "[Graft disease and epidemic keratoconjunctivitis]."
|2.||Laser In Situ Keratomileusis (LASIK)
08/30/2008 - "To report a patient who presented with epithelial ingrowth caused by viral keratoconjunctivitis 3 months after LASIK surgery. "
06/01/2004 - "This case shows that DLK may occur associated with a viral pseudomembranous keratoconjunctivitis in patients who have had LASIK. "
04/01/2003 - "Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery."
03/01/2001 - "Acute hemorrhagic keratoconjunctivitis after LASIK."
12/01/2000 - "We report two cases of acute haemorrhagic keratoconjunctivitis which occurred following laser in situ keratomileusis (LASIK) during an ongoing epidemic. "
04/01/1988 - "The authors recommend a trial of plasmapheresis in selected patients with recalcitrant and debilitating atopic keratoconjunctivitis when standard therapy proves unsuccessful."
04/01/1988 - "Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis."
04/01/1988 - "A 19-year-old woman with hyperimmunoglobulinemia E (the hyper-IgE syndrome [HIE]) and a 62-year-old man with atopic dermatitis experienced dramatic improvement in their chronic ocular symptoms and signs of atopic keratoconjunctivitis after plasmapheresis was instituted. "
05/01/1992 - "In 1989 in the authors' hospital four plasmaphereses were performed in a patient treated with steroids on account of severe atopic keratoconjunctivitis with suspicion of hyperimmunoglobulinaemia IgE. "
06/15/2004 - "Seven subjects with various ocular surface disorders were selected for the procedure: one patient had an extensive conjunctival nevus, three patients had pterygium, two patients had persistent leaking trabeculectomy blebs, and one patient had bilateral superior limbic keratoconjunctivitis. "
01/01/2010 - "To our knowledge this is the first report of topical tacrolimus 0.1% ointment applied to the conjunctival sac for the treatment of atopic keratoconjunctivitis, vernal keratoconjunctivitis and the post-operative management of trabeculectomy and graft rejection in steroid responders. "
11/01/2008 - "Autologous serum eye drops have been reported to be effective for the treatment of severe dry eye-related ocular surface disorders (Sjögren's syndrome), and also other entities such as superior limbic keratoconjunctivitis, graft-versus-host disease, Stevens-Johnson syndrome, ocular cicatricial pemphigoid, recurrent or persistent corneal erosions, neurotrophic keratopathy, Mooren's ulcer, aniridic keratopathy, filtering blebs after trabeculectomy, and post-keratorefractive surgery. "